GB1229888A - - Google Patents
Info
- Publication number
- GB1229888A GB1229888A GB1229888DA GB1229888A GB 1229888 A GB1229888 A GB 1229888A GB 1229888D A GB1229888D A GB 1229888DA GB 1229888 A GB1229888 A GB 1229888A
- Authority
- GB
- United Kingdom
- Prior art keywords
- informationally
- viruses
- antigen
- influenza
- vaccines
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
Abstract
1,229,888. Vaccines. D. JACHERTZ. 19 June, 1968 [19 June, 1967], No. 29232/68. Heading A5B. Vaccines which are antigen-free and comprise aqueous suspensions of informationally active ribonucleic acid are prepared by stimulating with an antigen corresponding to the required informationally active RNA as system of immunologically competent cells or a cellfree system obtained therefrom, and isolating an aqueous suspension of the informationally active RNA. The vaccine may also contain an adjuvant such as aluminium hydroxide or phosphate and/or a pharmaceutically suitable carrier. The immunologically competent cells may be from human or animal lymphs, lymph nodes, spleen, peritoneal exudates and pheripheral leukocytes (blood). The antigen used may be from bacteria, viruses or their subunits or snake poison, e.g. tetanus and diphtheria toxin; the products of metabolism or degradation of Bordetella pertussio, Mycobacterlium tuberculosis, salmonellae, shigellae, brucellae; influenza, influenza haemagglutinim, polio viruses or their protein envelope, measles, rabies, foot and mouth disease, smallpox, swine fever, distemper, hepatitis contagiosa canis and encephalitis viruses.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DEJ0033936 | 1967-06-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1229888A true GB1229888A (en) | 1971-04-28 |
Family
ID=7204943
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB1229888D Expired GB1229888A (en) | 1967-06-19 | 1968-06-19 |
Country Status (13)
| Country | Link |
|---|---|
| AT (1) | AT282821B (en) |
| BE (1) | BE716806A (en) |
| BR (1) | BR6899970D0 (en) |
| CH (1) | CH513241A (en) |
| DE (1) | DE1617545C2 (en) |
| DK (1) | DK119724B (en) |
| ES (1) | ES355121A1 (en) |
| FR (2) | FR1588820A (en) |
| GB (1) | GB1229888A (en) |
| IE (1) | IE32140B1 (en) |
| IL (1) | IL30168A (en) |
| NL (1) | NL6808486A (en) |
| NO (1) | NO124840B (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4224404A (en) | 1976-12-16 | 1980-09-23 | The International Institute Of Differentiation Limited | Production of specific immune nucleic acids cell dialysates and antibodies |
| GB2216416A (en) * | 1988-03-11 | 1989-10-11 | Sandoz Ltd | Immunostimulating compositions comprising nucleobase sources |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE754934A (en) * | 1969-08-16 | 1971-02-17 | Jachertz Diether | RNA-MESSENGER ENZYMATIC PRODUCTION PROCESS |
| DE3115559A1 (en) * | 1981-04-16 | 1982-10-28 | Kommanditgesellschaft Schwarzhaupt, 5000 Köln | HIGH PURIFIED INFORMATIVE RIBONUCLEIC ACID (I-RNS), METHOD FOR THE PRODUCTION AND USE THEREOF |
| US6214804B1 (en) | 1989-03-21 | 2001-04-10 | Vical Incorporated | Induction of a protective immune response in a mammal by injecting a DNA sequence |
| US5703055A (en) | 1989-03-21 | 1997-12-30 | Wisconsin Alumni Research Foundation | Generation of antibodies through lipid mediated DNA delivery |
| US6867195B1 (en) | 1989-03-21 | 2005-03-15 | Vical Incorporated | Lipid-mediated polynucleotide administration to reduce likelihood of subject's becoming infected |
| US6673776B1 (en) | 1989-03-21 | 2004-01-06 | Vical Incorporated | Expression of exogenous polynucleotide sequences in a vertebrate, mammal, fish, bird or human |
-
1967
- 1967-06-19 DE DE1617545A patent/DE1617545C2/en not_active Expired
-
1968
- 1968-06-12 IL IL30168A patent/IL30168A/en unknown
- 1968-06-15 NO NO2340/68A patent/NO124840B/no unknown
- 1968-06-17 NL NL6808486A patent/NL6808486A/xx unknown
- 1968-06-17 AT AT576668A patent/AT282821B/en not_active IP Right Cessation
- 1968-06-17 IE IE713/68A patent/IE32140B1/en unknown
- 1968-06-17 CH CH893668A patent/CH513241A/en not_active IP Right Cessation
- 1968-06-18 ES ES355121A patent/ES355121A1/en not_active Expired
- 1968-06-18 DK DK286268AA patent/DK119724B/en unknown
- 1968-06-19 BE BE716806D patent/BE716806A/xx unknown
- 1968-06-19 FR FR1588820D patent/FR1588820A/fr not_active Expired
- 1968-06-19 GB GB1229888D patent/GB1229888A/en not_active Expired
- 1968-06-19 BR BR199970/68A patent/BR6899970D0/en unknown
- 1968-09-18 FR FR166589A patent/FR7781M/fr not_active Expired
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4224404A (en) | 1976-12-16 | 1980-09-23 | The International Institute Of Differentiation Limited | Production of specific immune nucleic acids cell dialysates and antibodies |
| GB2216416A (en) * | 1988-03-11 | 1989-10-11 | Sandoz Ltd | Immunostimulating compositions comprising nucleobase sources |
| GB2216416B (en) * | 1988-03-11 | 1992-06-24 | Sandoz Ltd | Nucleobase source for the stimulation of the immune system |
Also Published As
| Publication number | Publication date |
|---|---|
| DK119724B (en) | 1971-02-15 |
| IL30168A0 (en) | 1968-08-22 |
| BR6899970D0 (en) | 1973-02-13 |
| AT282821B (en) | 1970-07-10 |
| FR7781M (en) | 1970-03-23 |
| FR1588820A (en) | 1970-03-16 |
| DE1617545A1 (en) | 1971-04-01 |
| IE32140B1 (en) | 1973-04-18 |
| DE1617545C2 (en) | 1983-11-03 |
| CH513241A (en) | 1971-09-30 |
| NO124840B (en) | 1972-06-12 |
| IE32140L (en) | 1968-12-19 |
| IL30168A (en) | 1973-05-31 |
| ES355121A1 (en) | 1969-11-16 |
| BE716806A (en) | 1968-12-19 |
| NL6808486A (en) | 1968-12-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Wiktor et al. | Cultivation of rabies virus in human diploid cell strain WI-38 | |
| Oxford et al. | The specificity of the anti-haemagglutinin antibody response induced in man by inactivated influenza vaccines and by natural infection | |
| Wiktor et al. | Human cell culture rabies vaccine: antibody response in man | |
| Webster et al. | Potentiation of the immune response to influenza virus subunit vaccines | |
| Zygraich et al. | In vivo and in vitro properties of a temperature sensitive mutant of infectious bovine rhinotracheitis virus | |
| CA1045546A (en) | Highly attenuated cytomegalovirus vaccine and production thereof | |
| Atanasiu et al. | Rabies neutralizing antibody response to different schedules of serum and vaccine inoculations in non-exposed persons: Part 3 | |
| Nicholson et al. | Immune responses of humans to a human diploid cell strain of rabies virus vaccine: lymphocyte transformation, production of virus-neutralizing antibody, and induction of interferon | |
| GB1229888A (en) | ||
| US3927208A (en) | Live bovine adenovirus vaccines, preparation thereof and method of vaccination using them | |
| Zinkernagel | Antiviral T-cell memory? | |
| Fekadu et al. | An immune stimulating complex (ISCOM) subunit rabies vaccine protects dogs and mice against street rabies challenge | |
| Glasgow et al. | Isoprinosine: lack of antiviral activity in experimental model infections | |
| Reiss et al. | Specificity of the helper T cell for the cytolytic T lymphocyte response to influenza viruses | |
| Holper et al. | Further studies on multiplication, serology and antigenicity of 2060 and JH viruses | |
| MOGABGAB | Upper respiratory illness vaccines: Perspectives and trials | |
| US3629413A (en) | Polyvalent bovine vaccines and methods of making and using same | |
| Millian et al. | Antibody response of man to canine distemper virus | |
| Norrby et al. | Humoral immunity to canine distemper after immunization of dogs with inactivated and live measles virus | |
| Laver et al. | Preparation and immunogenicity of a purified influenza virus haemagglutinin and neuraminidase subunit vaccine | |
| US5006335A (en) | Live vaccine against mumps and process for obtaining thereof | |
| McNeill | The antibody response of rabbits to inactivated vaccinia virus | |
| Musser et al. | Production of rubella virus vaccine: Live, attenuated in canine renal cell cultures | |
| Luzzio | Demonstration of blood group substance A bound to Pasteurella pestis | |
| Srivastava et al. | Studies on the immunogenicity of Streptococcus equi vaccines in foals. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed [section 19, patents act 1949] | ||
| PCNP | Patent ceased through non-payment of renewal fee |